Sunday News XGN..15.69..Care of patients with autoimmune diseases. Announced strong fourth quarter results..Core testing business delivered record revenue Market Cap of $191 Million..VERY LOW FLOAT of $4 MIllion Short term assets far exceed short and long term liabilities Cash $61 million can cover, cash burn of $14 millionRevenue forecast to grow 35% per year High Target price of $32.00...Low of 20.00
News Out Early Maybe From Bearish and Strong Sell To Buy MESO..Global leader in allogenic cellular medicines that treat inflammatory diseases This morning announced positive results from Dream-HF Phase 3 Trial with patients with chronic heart failure. Single dose of Revascor resulted in substantial reductions in strokes and cardiac deaths.. Closed Friday 8.66 Market Cap $ 1 Billion..float 93 Million..Short term assets exceed short and long term liabilities..Cash $108 Million..Cash Burn 71 Million Revenue projected Growth 115% per year. Median Target price $13.00..High of $20.00..Low of $6.00
Pre-Market Mover TRXC..Up 120%..1.95 Medical Device Company involved in Robotic Surgery.. Market Cap $115 Million...float 79 Million Revenue Growth 83% compared to Industry average of 15% Upgraded to Zacks grade 2 Buy..StockTA Bullish Long and Short and A Barchart Strong Buy Short term assets of $37 Million exceeds Short term liabilities of $11 Million and Long term $6 Million Wall Street rates 71 out of 100 Owned by 84 Financial Institutions
NSPR..Medical Devices Up 10% pre-market...59 Upgraded to Zacks 2 Buy..StockTA Bullish Short and Long and A Barchart Buy
News Just Out ACER...2.49..Pharmaceutical Company Revenue up 40% Considered undervalued with equity to increase for sharholders 180% over next four years Low Float of 4 million Median Target price of $10.00
UTSI..1.56..Global Telecommunications Infrastructure Provider News this morning expanding cooperation with mobile operator Low Float of 11 million Short term assets of $119 Million exceeds Short term liabilities of $45 Million and Long term liabilities of $ 2 Million Median Target Price of 2.50 StockTA Bullish Short and Long
PNNX..43..Being Pumped Process of name change..Tech Company helping Businesses grow using social media.. Growing customer base..Doubled revenue in Q4 compared to Q3 StockTA Bullish Short and Long..A Barchart Buy
MESO..After-hours dipped to 10.46 Today Mesoblast presented Heart Failure results at the Investor Healthcare Conference. Theri Rexlemestrocel-L may provide a major breakthrough in reducing heart failure progression and mortality when used early. Stock price a bargain at this level..
ONTX....69 Bio-pharm focused on developing and discovering novel products to treat cancer.. Market Cap $127 million Undervalued with Target Price of 2.00 StockTA Very Bullish Short and A Barchart Buy
Buy and Hold OCGN..2.49..Ocugen Covaxin..Covid-19 Vaccine will start to be distributed in India today. Bhart Bioteck partner with US based Ocugen Ocugen has U.S. rights to Vaccine.
Two pre-market Movers USWS..Oilfield service provider..This morning announced finalized extention of contract to provide electric hydraulic fraturing in Appalachin Basin Up 90% from close of .52 to .90 Float of 41M...Liabilities do exceed assets TTOO..Up 45%..from close of 1.60 to 2.33 T2 Biosystems provides rapid in vitro diagnostic tests in hospitals and labs Undervalued with solid value considering it's book value Short term assets exceed Short term and Long Term liabilities..Cash and Investments can cover Cash burn Grew 45% which is above Diagnostic Industry average of 17% Company had 90% growth last year. StockTA Intermediate Buy and A Barchart Buy Median Target price 3.50
IRIX..Up pre-market 30% from close of 2.86 to this morning 3.74 Iridex in the business of develping..manufacturing and marketing laser-based medical systems.. Short term assets far exceed Short and Long term liabilities Cash on hand $11 million Cash Burn $3 million Considered significantly undervalued Float of 10 millionA Barchart Buy Stop loss of 2.75 Median Target price of 4.50 Don't throw the dirt on their grave yet OCGN down to 2.32 after reaching High last week of 3.50 with news of their partnership with Indian Firm for Covaxin..Covi-19 Vaccine..Today they start distribution in India..Ocugen has US rights if and when it comes in front of US FDA..OCGN will see better days again. MESO at 10.00..after reaching high of 13.70 and a pre-market rise to 17.00 They will be back as their Clinical trials continue..
Stim..11.67..Up 16% after hours 13.51 Neuronetics commercial stage medical tech Company Uptick on price after coming out with positive news on revenue..25% higher 4th quarter than 3rd quarter. $221 million Market Cap...Low Float of 10 millionUndervalued..Short term assets exceed Short and Long term liabilities Cash and Investments of $52 Million Cash Burn of $34 Million...70 Institutions hold 71% of stock Hedge Funds Bullish Barchart Strong Buy Target Price High of 15.00.. Low 8.00
MTRX..Up Tuesday..12.23 Matrix..Announced late yesterday ..Chart Industries and Matrix Service Execute Commercial Hydrogen Memorandum Of Understanding Matrix provides engineering, fabrication, infrastructure and construction to oil, gas and power sector. Undervalued..Market Cap $305Million...Short term assets $331 Million exceeds Short term liabilites $170 Million and Long term liabilities of $35 Million Cash $82 Million Cash Burn $39 Million Median Target Price 13.50..Low of 12.00 High 15.00 Candles still show Bullish Direction
